Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Operating activities:    
Net loss $ (17,894) $ (14,945)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,381 653
Amortization of deferred rent (27) (28)
Stock-based compensation expense 2,552 1,259
Gain on change in fair value of warrant liability (3,030) 0
Changes in operating assets and liabilities:    
Accounts receivable (131) (636)
Inventories (1,026) (379)
Note receivable (75) 0
Prepaid expense and other assets (94) (338)
Deferred costs of revenue 4,498 (776)
Accounts payable (1,335) 1,365
Accrued liabilities 1,279 (188)
Deferred revenues (6,653) 931
Net cash used in operating activities (20,555) (13,082)
Investing activities:    
Acquisition of property and equipment (728) (962)
Net cash used in investing activities (728) (962)
Financing activities:    
Principal payments on note payable (58) (40)
Fees paid related to 2015 issuance of convertible preferred stock (173) 0
Proceeds from issuance of common stock 14,694 0
Proceeds from exercise of stock options 74 80
Proceeds from exercise of warrants 0 52
Net cash provided by financing activities 14,537 92
Effect of exchange rate changes on cash (6) 0
Net decrease in cash (6,752) (13,952)
Cash at beginning of period 19,552 25,190
Cash at end of period $ 12,800 $ 11,238